Selecta Biosciences (SELB) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts SELB Hot Sheet
Join SI Premium – FREE
Selecta Biosciences (NASDAQ: SELB) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $11.09 million.
For earnings history and earnings-related data on Selecta Biosciences (SELB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
